Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients

Transplant International

Volumn 19, Issue 8, 2006, Pages 688-690

  Zoumot, Zaid ^a   Carby, Martin ^a   Hall, Anne V ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA ANTIGEN CLASS 2; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VORICONAZOLE;

ACUTE GRAFT REJECTION; ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRONCHIECTASIS; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DYSPNEA; FEMALE; FOLLOW UP; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; LETTER; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NEUROTOXICITY; PRIORITY JOURNAL; REMISSION; SPIROMETRY; SYMPTOM; TRACHEOBRONCHITIS;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 33745713631     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00328.x     Document Type: Letter

References (11)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781.
2. Mehrad B, Paciocco G, Martinez FJ, Clark Ojo T, Iannettoni MD, Lynch JP. Spectrum of Aspergillus infection in lung transplant recipients. Case series and review of the literature. Chest 2001; 119: 169.
3. Ascioglu S, Rex JH, de Pauw B, et al. Invasive fungal infections cooperative group of the European Organization for Research and Treatment of Cancer; mycoses study group of the national institute of allergy and infectious diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7.
4. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608.
5. Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998; 26: 1383.
6. Herbrecht R, Denning DW, Patterson TF, et al for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergiollosis. N Engl J Med 2002; 347: 408
7. Fortún J, Martín-Dávila P, Sánchez MA, et al. Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur J Clin Microbiol Infect Dis 2003; 22: 408.
8. Maertens J, Raad I, Petrikkos G, et al for the Caspofungin Salvage Aspergillosis is Study Group. Efficacy and safety of caspofung in for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39: 1563
9. Carby MC, Hodson ME, Banner NR. Refractory pulmonary aspergillosis treated with caspofungin after heart-lung transplantation. Transpl Int 2004; 17: 545.
10. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391.
11. Shlobin OA, Dropulic LK, Orens JB, et al. Mediastinal mass due to Aspegillus fumigatus after lung transplantation: a case report. J Heart Lung Transplant 2005; 24: 1991.